<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33615605</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2184</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Cell proliferation</Title><ISOAbbreviation>Cell Prolif</ISOAbbreviation></Journal><ArticleTitle>PAK4 suppresses motor neuron degeneration in hSOD1<sup>G93A</sup> -linked amyotrophic lateral sclerosis cell and rat models.</ArticleTitle><Pagination><StartPage>e13003</StartPage><MedlinePgn>e13003</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13003</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/cpr.13003</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of motor neurons (MN). CREB pathway-mediated inhibition of apoptosis contributes to neuron protection, and PAK4 activates CREB signalling in diverse cell types. This study aimed to investigate PAK4's effect and mechanism of action in ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analysed RNA levels by qRT-PCR, protein levels by immunofluorescence and Western blotting, and apoptosis by flow cytometry and TUNEL staining. Cell transfection was performed for in vitro experiment. Mice were injected intraspinally to evaluate PAK4 function in vivo experiment. Rotarod test was performed to measure motor function.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The expression and activation of PAK4 significantly decreased in the cell and mouse models of ALS as the disease progressed, which was caused by the negative regulation of miR-9-5p. Silencing of PAK4 increased the apoptosis of MN by inhibiting CREB-mediated neuroprotection, whereas overexpression of PAK4 protected MN from hSOD1<sup>G93A</sup> -induced degeneration by activating CREB signalling. The neuroprotective effect of PAK4 was markedly inhibited by CREB inhibitor. In ALS models, the PAK4/CREB pathway was inhibited, and cell apoptosis increased. In vivo experiments revealed that PAK4 overexpression in the spinal neurons of hSOD1<sup>G93A</sup> mice suppressed MN degeneration, prolonged survival and promoted the CREB pathway.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PAK4 protects MN from degeneration by activating the anti-apoptotic effects of CREB signalling, suggesting it may be a therapeutic target in ALS.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Cell Proliferation Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cong</LastName><ForeName>Chaohua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Clinical College of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Weiwei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Clinical College of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chunting</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Clinical College of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Clinical College of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yueqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Clinical College of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xudong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Clinical College of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shuyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Clinical College of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huo</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Clinical College of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongyong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Clinical College of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Clinical College of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Honglin</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5062-8846</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The First Clinical College of Harbin Medical University, Harbin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>91849133</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>81571227</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>YJSKYCX2018-32HYD</GrantID><Agency>Innovative Research Program for Graduates of Harbin Medical University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Prolif</MedlineTA><NlmUniqueID>9105195</NlmUniqueID><ISSNLinking>0960-7722</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C551804">MIRN9 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.48</RegistryNumber><NameOfSubstance UI="D050882">CREB-Binding Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.48</RegistryNumber><NameOfSubstance UI="C494364">Crebbp protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C492065">Pak4 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D054462">p21-Activated Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050882" MajorTopicYN="N">CREB-Binding Protein</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054462" MajorTopicYN="N">p21-Activated Kinases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33615605</ArticleId><ArticleId IdType="pmc">PMC8016643</ArticleId><ArticleId IdType="doi">10.1111/cpr.13003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zufir&#xed;a M, Gil&#x2010;Bea FJ, Fern&#xe1;ndez&#x2010;Torr&#xf3;n R, et al. ALS: a bucket of genes, environment, metabolism and unknown ingredients. Prog Neurogibol. 2016;142:104&#x2010;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">27236050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al&#x2010;Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17085.</Citation><ArticleIdList><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerc P, Lipnick S, Willett C. A look into the future of ALS research. Drug Discov Today. 2016;21(6):939&#x2010;949.</Citation><ArticleIdList><ArticleId IdType="pubmed">26861067</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, et al. TDP&#x2010;43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319(5870):1668&#x2010;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, Walsh C, Lynch C, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta&#x2010;analysis. J Neurol Neurosurg Psychiatry. 2011;82(6):623&#x2010;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">21047878</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17(1):17&#x2010;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Al&#x2010;Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know?. Nat Rev Neurol. 2011;7(11):603&#x2010;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">21989245</ArticleId></ArticleIdList></Reference><Reference><Citation>Majoor&#x2010;Krakauer D, Willems PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet. 2003;63(2):83&#x2010;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">12630951</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013;14(4):248&#x2010;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264(5166):1772&#x2010;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65(Suppl 1):S3&#x2010;S9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19191304</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994;330(9):585&#x2010;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino H, Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study). Amyotroph Lateral Scler. 2006;7(4):241&#x2010;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">17127563</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Won J, Karlsson MG, et al. CREB regulates excitability and the allocation of memory to subsets of neurons in the amygdala. Nat Neurosci. 2009;12(11):1438&#x2010;1443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2783698</ArticleId><ArticleId IdType="pubmed">19783993</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Green T, Saal D, et al. CREB modulates excitability of nucleus accumbens neurons. Nat Neurosci. 2006;9(4):475&#x2010;477.</Citation><ArticleIdList><ArticleId IdType="pubmed">16520736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez de Armentia M, Jancic D, Olivares R, Alarcon JM, Kandel ER, Barco A. cAMP response element&#x2010;binding protein&#x2010;mediated gene expression increases the intrinsic excitability of CA1 pyramidal neurons. J Neurosci. 2007;27(50):13909&#x2010;13918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673625</ArticleId><ArticleId IdType="pubmed">18077703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargin D, Mercaldo V, Yiu AP, et al. CREB regulates spine density of lateral amygdala neurons: implications for memory allocation. Front Behav Neurosci. 2013;7:209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3868910</ArticleId><ArticleId IdType="pubmed">24391565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonze BE, Riccio A, Cohen S, Ginty DD. Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron. 2002;34(3):371&#x2010;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">11988169</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Zhang C, Takemori H, Zhou Y, Xiong ZQ. TORC1 regulates activity&#x2010;dependent CREB&#x2010;target gene transcription and dendritic growth of developing cortical neurons. J Neurosci. 2009;29(8):2334&#x2010;2343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6666266</ArticleId><ArticleId IdType="pubmed">19244510</ArticleId></ArticleIdList></Reference><Reference><Citation>Viosca J, Lopez de Armentia M, Jancic D, Barco A. Enhanced CREB&#x2010;dependent gene expression increases the excitability of neurons in the basal amygdala and primes the consolidation of contextual and cued fear memory. Learn Mem. 2009;16(3):193&#x2010;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">19237641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi RK, Hennessey T, Johri A, et al. Transducer of regulated CREB&#x2010;binding proteins (TORCs) transcription and function is impaired in Huntington's disease. Hum Mol Genet. 2012;21(15):3474&#x2010;3488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3491961</ArticleId><ArticleId IdType="pubmed">22589249</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong H, Cohen DE, Cui L, et al. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat Med. 2011;18(1):159&#x2010;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3509213</ArticleId><ArticleId IdType="pubmed">22179316</ArticleId></ArticleIdList></Reference><Reference><Citation>Mabuchi T, Kitagawa K, Kuwabara K, et al. Phosphorylation of cAMP response element&#x2010;binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J Neurosci. 2001;21(23):9204&#x2010;9213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763920</ArticleId><ArticleId IdType="pubmed">11717354</ArticleId></ArticleIdList></Reference><Reference><Citation>Won SY, Park MH, You ST, et al. Nigral dopaminergic PAK4 prevents neurodegeneration in rat models of Parkinson's disease. Sci Transl Med. 2016;8(367):367ra170.</Citation><ArticleIdList><ArticleId IdType="pubmed">27903866</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita M, Nonaka T, Hirai S, et al. Distinct pathways leading to TDP&#x2010;43&#x2010;induced cellular dysfunctions. Hum Mol Genet. 2014;23(16):4345&#x2010;4356.</Citation><ArticleIdList><ArticleId IdType="pubmed">24698978</ArticleId></ArticleIdList></Reference><Reference><Citation>Espa&#xf1;a J, Valero J, Mi&#xf1;ano&#x2010;Molina AJ, et al. Beta&#x2010;Amyloid disrupts activity&#x2010;dependent gene transcription required for memory through the CREB coactivator CRTC1. J Neurosci. 2010;30(28):9402&#x2010;9410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632424</ArticleId><ArticleId IdType="pubmed">20631169</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzog JJ, Xu W, Deshpande M, et al. TDP&#x2010;43 dysfunction restricts dendritic complexity by inhibiting CREB activation and altering gene expression. Proc Natl Acad Sci USA. 2020;117(21):11760&#x2010;11769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260973</ArticleId><ArticleId IdType="pubmed">32393629</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon GS, Im W, Shim YM, et al. Neuroprotective effect of human adipose stem cell&#x2010;derived extract in amyotrophic lateral sclerosis. Neurochem Res. 2016;41(4):913&#x2010;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">26646002</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Wang S, Wang X, et al. Lithium facilitates removal of misfolded proteins and attenuated faulty interaction between mutant SOD1 and p&#x2010;CREB (Ser133) through enhanced autophagy in mutant hSOD1G93A transfected neuronal cell lines. Mol Biol Rep. 2019;46(6):6299&#x2010;6309.</Citation><ArticleIdList><ArticleId IdType="pubmed">31529340</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias&#x2010;Romero LE, Chernoff J. A tale of two Paks. Biol Cell. 2008;100(2):97&#x2010;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">18199048</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S, Mizuta H, Rubinsztein DC. p21&#x2010;activated kinase 1 promotes soluble mutant huntingtin self&#x2010;interaction and enhances toxicity. Hum Mol Genet. 2008;17(6):895&#x2010;905.</Citation><ArticleIdList><ArticleId IdType="pubmed">18065495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma QL, Yang F, Frautschy SA, Cole GM. PAK in Alzheimer disease, Huntington disease and X&#x2010;linked mental retardation. Cell Logist. 2012;2(2):117&#x2010;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3490962</ArticleId><ArticleId IdType="pubmed">23162743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreis P, Th&#xe9;venot E, Rousseau V, Boda B, Muller D, Barnier JV. The p21&#x2010;activated kinase 3 implicated in mental retardation regulates spine morphogenesis through a Cdc42&#x2010;dependent pathway. J Biol Chem. 2007;282(29):21497&#x2010;21506.</Citation><ArticleIdList><ArticleId IdType="pubmed">17537723</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekrasova T, Jobes ML, Ting JH, Wagner GC, Minden A. Targeted disruption of the Pak5 and Pak6 genes in mice leads to deficits in learning and locomotion. Dev Biol. 2008;322(1):95&#x2010;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">18675265</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan C, Nath N, Liberto M, Minden A. PAK5, a new brain&#x2010;specific kinase, promotes neurite outgrowth in N1E&#x2013;115 cells. Mol Cell Biol. 2002;22(2):567&#x2010;577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC139731</ArticleId><ArticleId IdType="pubmed">11756552</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu J, Li X, Novitch BG, et al. PAK4 kinase is essential for embryonic viability and for proper neuronal development. Mol Cell Biol. 2003;23(20):7122&#x2010;7133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230313</ArticleId><ArticleId IdType="pubmed">14517283</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J, Hegde PM, Hegde ML. Loss of endosomal recycling factor RAB11 coupled with complex regulation of MAPK/ERK/AKT signaling in postmortem spinal cord specimens of sporadic amyotrophic lateral sclerosis patients. Mol Brain. 2019;12(1):55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6567394</ArticleId><ArticleId IdType="pubmed">31196199</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan H, Chen M, Pang D, et al. LanCL1 promotes motor neuron survival and extends the lifespan of amyotrophic lateral sclerosis mice. Cell Death Differ. 2020;27(4):1369&#x2010;1382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206132</ArticleId><ArticleId IdType="pubmed">31570855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J, Ning K, Ferraiuolo L, et al. Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1&#x2010;related amyotrophic lateral sclerosis. Brain. 2011;134(Pt 2):506&#x2010;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3030763</ArticleId><ArticleId IdType="pubmed">21228060</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Yang Y, Liang W, et al. Neuroprotection by urate on the mutant hSOD1&#x2010;related cellular and Drosophila models of amyotrophic lateral sclerosis: implication for GSH synthesis via activating Akt/GSK3&#x3b2;/Nrf2/GCLC pathways. Brain Res Bull. 2019;146:287&#x2010;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">30690059</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi N, Bhardwaj A, Singh AP, McClellan S, Carter JE, Singh S. p&#x2010;21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT&#x2010; and ERK&#x2010;dependent activation of NF&#x2010;&#x3ba;B pathway. Oncotarget. 2014;5(18):8778&#x2010;8789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4226721</ArticleId><ArticleId IdType="pubmed">25238288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuijl C, Savage ND, Marsman M, et al. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature. 2007;450(7170):725&#x2010;730.</Citation><ArticleIdList><ArticleId IdType="pubmed">18046412</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MH, Lee HS, Lee CS, et al. p21&#x2010;Activated kinase 4 promotes prostate cancer progression through CREB. Oncogene. 2013;32(19):2475&#x2010;2482.</Citation><ArticleIdList><ArticleId IdType="pubmed">22710715</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun CY, You ST, Kim JH, et al. p21&#x2010;activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and &#x3b2;&#x2010;catenin/MITF pathways. J Invest Dermatol. 2015;135(5):1385&#x2010;1394.</Citation><ArticleIdList><ArticleId IdType="pubmed">25560280</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu BJ, Lee H, Kim SH, et al. PF&#x2010;3758309, p21&#x2010;activated kinase 4 inhibitor, suppresses migration and invasion of A549 human lung cancer cells via regulation of CREB, NF&#x2010;&#x3ba;B, and &#x3b2;&#x2010;catenin signalings. Mol Cell Biochem. 2014;389(1&#x2010;2):69&#x2010;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">24366569</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng HL, Leng Y, Ma CH, Zhang J, Ren M, Chuang DM. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience. 2008;155(3):567&#x2010;572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2709275</ArticleId><ArticleId IdType="pubmed">18640245</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Ren M, Jiang H, et al. Downregulated AEG&#x2010;1 together with inhibited PI3K/Akt pathway is associated with reduced viability of motor neurons in an ALS model. Mol Cell Neurosci. 2015;68:303&#x2010;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">26320681</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YQ, Zheng YH, Zhang CT, et al. Wild&#x2010;type p53&#x2010;induced phosphatase 1 down&#x2010;regulation promotes apoptosis by activating the DNA damage&#x2010;response pathway in amyotrophic lateral sclerosis. Neurobiol Dis. 2020;134:104648.</Citation><ArticleIdList><ArticleId IdType="pubmed">31676238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter DD, Cashman N, Morris&#x2010;Valero R, Bulock JW, Adams SP, Sanes JR. An LRE (leucine&#x2010;arginine&#x2010;glutamate)&#x2010;dependent mechanism for adhesion of neurons to S&#x2010;laminin. J Neurosci. 1991;11(12):3960&#x2010;3971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6575296</ArticleId><ArticleId IdType="pubmed">1683902</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman NR, Durham HD, Blusztajn JK, et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn. 1992;194(3):209&#x2010;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Durham HD, Dahrouge S, Cashman NR. Evaluation of the spinal cord neuron X neuroblastoma hybrid cell line NSC&#x2010;34 as a model for neurotoxicity testing. Neurotoxicology. 1993;14(4):387&#x2010;395.</Citation><ArticleIdList><ArticleId IdType="pubmed">7909362</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Al&#x2010;Ramahi I, Tan Q, et al. RAS&#x2010;MAPK&#x2010;MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1. Nature. 2013;498(7454):325&#x2010;331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4020154</ArticleId><ArticleId IdType="pubmed">23719381</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupaimoole R, Calin GA, Lopez&#x2010;Berestein G, Sood AK. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 2016;6(3):235&#x2010;246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4783232</ArticleId><ArticleId IdType="pubmed">26865249</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue J, Chen LZ, Li ZZ, Hu YY, Yan SP, Liu LY. MicroRNA&#x2010;433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4). Mol Cell Biochem. 2015;399(1&#x2013;2):77&#x2010;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">25410752</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia M, Wei J, Tong K. MiR&#x2010;224 promotes proliferation and migration of gastric cancer cells through targeting PAK4. Pharmazie. 2016;71(8):460&#x2010;464.</Citation><ArticleIdList><ArticleId IdType="pubmed">29442033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng B, Shi W, Tan G. MiR&#x2010;199a/b&#x2010;3p inhibits gastric cancer cell proliferation via down&#x2010;regulating PAK4/MEK/ERK signaling pathway. BMC Cancer. 2018;18(1):34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5756398</ArticleId><ArticleId IdType="pubmed">29304764</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Gao Q, Chen Y, Li Z, Yue L, Cao Y. PAK4, a target of miR&#x2010;9&#x2010;5p, promotes cell proliferation and inhibits apoptosis in colorectal cancer. Cell Mol Biol Lett. 2019;24:58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6842216</ArticleId><ArticleId IdType="pubmed">31728150</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R, Wyles M, Heath PR, et al. Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity. Front Neurosci. 2018;11:731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo A, Qu J, Cammarano MS, et al. PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J. 1998;17(22):6527&#x2010;6540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1171000</ArticleId><ArticleId IdType="pubmed">9822598</ArticleId></ArticleIdList></Reference><Reference><Citation>Won SY, Park JJ, Shin EY, Kim EG. PAK4 signaling in health and disease: defining the PAK4&#x2010;CREB axis. Exp Mol Med. 2019;51(2):1&#x2010;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6372590</ArticleId><ArticleId IdType="pubmed">30755582</ArticleId></ArticleIdList></Reference><Reference><Citation>Radu M, Semenova G, Kosoff R, Chernoff J. PAK signalling during the development and progression of cancer. Nat Rev Cancer. 2014;14(1):13&#x2010;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4115244</ArticleId><ArticleId IdType="pubmed">24505617</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulciniti M, Martinez&#x2010;Lopez J, Senapedis W, et al. Functional role and therapeutic targeting of p21&#x2010;activated kinase 4 in multiple myeloma. Blood. 2017;129(16):2233&#x2010;2245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5399480</ArticleId><ArticleId IdType="pubmed">28096095</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa TDF, Zhuang T, Lorent J, et al. PAK4 suppresses RELB to prevent senescence&#x2010;like growth arrest in breast cancer. Nat Commun. 2019;10(1):3589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6689091</ArticleId><ArticleId IdType="pubmed">31399573</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YM, Ashok Kumar K, Ju DT, et al. Dipeptide IF prevents the effects of hypertension&#x2010;induced Alzheimer's disease on long&#x2010;term memory in the cortex of spontaneously hypertensive rats. Environ Toxicol. 2020;35(5):570&#x2010;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">31889399</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SY, Lopez&#x2010;Gonzalez R, Krishnan G, et al. C9ORF72&#x2010;ALS/FTD&#x2010;associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat Neurosci. 2019;22(6):851&#x2010;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnesutta N, Qu J, Minden A. The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J Biol Chem. 2001;276(17):14414&#x2010;14419.</Citation><ArticleIdList><ArticleId IdType="pubmed">11278822</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JH, Ko HS, Kang H, et al. PARIS (ZNF746) repression of PGC&#x2010;1&#x3b1; contributes to neurodegeneration in Parkinson's disease. Cell. 2011;144(5):689&#x2010;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3063894</ArticleId><ArticleId IdType="pubmed">21376232</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J, Yankner BA. Apoptosis in the nervous system. Nature. 2000;407(6805):802&#x2010;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">11048732</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F, Al&#x2010;Chalabi A, Ronnevi LO, et al. Amyotrophic lateral sclerosis and cancer: a register&#x2010;based study in Sweden. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(5&#x2010;6):362&#x2010;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5451142</ArticleId><ArticleId IdType="pubmed">23527497</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi ML, Rao BS, Seo JS, et al. Inhibition of p21&#x2010;activated kinase rescues symptoms of fragile X syndrome in mice. Proc Natl Acad Sci USA. 2007;104(27):11489&#x2010;11494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1899186</ArticleId><ArticleId IdType="pubmed">17592139</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen KM, Gleeson JG, Bagrodia S, et al. PAK3 mutation in nonsyndromic X&#x2010;linked mental retardation. Nat Genet. 1998;20(1):25&#x2010;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">9731525</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Ma QL, Calon F, et al. Role of p21&#x2010;activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat Neurosci. 2006;9(2):234&#x2010;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">16415866</ArticleId></ArticleIdList></Reference><Reference><Citation>Bondar VV, Adamski CJ, Onur TS, et al. PAK1 regulates ATXN1 levels providing an opportunity to modify its toxicity in spinocerebellar ataxia type 1. Hum Mol Genet. 2018;27(16):2863&#x2010;2873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077814</ArticleId><ArticleId IdType="pubmed">29860311</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolan BM, Duron SG, Campbell DA, et al. Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small&#x2010;molecule PAK inhibitor FRAX486. Proc Natl Acad Sci USA. 2013;110(14):5671&#x2010;5676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3619302</ArticleId><ArticleId IdType="pubmed">23509247</ArticleId></ArticleIdList></Reference><Reference><Citation>Civiero L, Cirnaru MD, Beilina A, et al. Leucine&#x2010;rich repeat kinase 2 interacts with p21&#x2010;activated kinase 6 to control neurite complexity in mammalian brain. J Neurochem. 2015;135(6):1242&#x2010;1256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4715492</ArticleId><ArticleId IdType="pubmed">26375402</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudor EL, Perkinton MS, Schmidt A, et al. ALS2/Alsin regulates Rac&#x2010;PAK signaling and neurite outgrowth. J Biol Chem. 2005;280(41):34735&#x2010;34740.</Citation><ArticleIdList><ArticleId IdType="pubmed">16049005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S, Hand CK, Osuga H, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet. 2001;29(2):166&#x2010;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">11586298</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly ZR, Scott KM, Abhinav K, et al. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph Lateral Scler. 2010;11(5):439&#x2010;442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman MH, de Jong SW, van Doormaal PT, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture&#x2010;recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82(10):1165&#x2010;1170.</Citation><ArticleIdList><ArticleId IdType="pubmed">21622937</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mora G, Calvo A, et al. Epidemiology of ALS in Italy: a 10&#x2010;year prospective population&#x2010;based study. Neurology. 2009;72(8):725&#x2010;731.</Citation><ArticleIdList><ArticleId IdType="pubmed">19237701</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape JA, Grose JH. The effects of diet and sex in amyotrophic lateral sclerosis. Rev Neurol (Paris). 2020;176(5):301&#x2010;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">32147204</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimojo Y, Kosaka K, Noda Y, Shimizu T, Shirasawa T. Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis. J Neurosci Res. 2010;88(4):896&#x2010;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">19798750</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink JH, B&#xe4;r PR, Joosten EA, Otten M, Wokke JH, van den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord. 2003;13(9):737&#x2010;743.</Citation><ArticleIdList><ArticleId IdType="pubmed">14561497</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape JA, Newey CR, Burrell HR, et al. Per&#x2010;Arnt&#x2010;Sim Kinase (PASK) deficiency increases cellular respiration on a standard diet and decreases liver triglyceride accumulation on a western high&#x2010;fat high&#x2010;sugar diet. Nutrients. 2018;10(12):1990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6316003</ArticleId><ArticleId IdType="pubmed">30558306</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>